For decades, the National Institutes of Health has distributed its vast research funding through a process insulated from politics by the judgment of peer scientists — a structure built on the premise that knowledge, not ideology, should guide inquiry. Now, the Trump administration is preparing to insert a two-person political board with veto power over biomedical grants, effectively subordinating scientific merit to presidential priorities. The move, already preceded by billions in frozen funding and keyword-based filtering of research proposals, raises a question as old as patronage itself:
Trump administration plans NIH funding board with veto power over research grants
Researchers face termination of scientific grants and hindered research programs due to ideological filtering of funding.
Either member could block funding for any research project.
Mark
So this board would just block grants the president doesn't like?
Mimi
Not exactly block—it would require unanimous approval. Either Vought or Bhattacharya could veto any grant. The idea is to align funding with administration priorities.
Luke
But what are those priorities? The reporting says "woke initiatives" and mentions keywords like "equity" and "climate change," but it doesn't spell out what research would actually be rejected.
Mimi
That's the point, though. The administration has already been flagging those keywords to restrict funding. This board would formalize that process.
Mark
And Bhattacharya is on the board? He's defended the current grant process.
Mimi
Yes, which creates an interesting dynamic. He's the NIH director but also part of the veto structure. It's unclear how much actual power he'd have.
Luke
The lawsuit claims First Amendment violation. But the government does get to decide where to spend money. What makes this different?
Mimi
The lawsuit argues the government can't use funding as a tool to suppress particular viewpoints or silence researchers with disfavored opinions. It's the targeting that's the problem, not the spending decision itself.
Mark
How much money are we talking about?
Mimi
Billions in grants have already been frozen or cut since Trump took office—health, nutrition, environment, disaster relief.
Luke
But the reporting doesn't say how much specifically would be affected by this new board. That's still unclear.
Mark
What happens next?
Mimi
The lawsuit will likely move forward, and the board itself may or may not be formally established depending on legal challenges and internal resistance.
Il Polso
- The administration is finalizing an executive order that would place two political appointees — including budget director Russell Vought — in a position to unilaterally block any NIH research grant, no matter its scientific merit.
- Billions in federal research funding have already been frozen or cut, and proposals containing words like 'equity,' 'climate change,' and 'gender' are being flagged and restricted before any formal board even convenes.
- Tension fractures the proposed structure from within: NIH director Jay Bhattacharya has publicly defended traditional grant-making, putting him at odds with Vought and the broader ideological agenda driving the overhaul.
- Researchers have responded with a class-action lawsuit, arguing the administration is weaponizing funding power to suppress disfavored scientific viewpoints in violation of the First Amendment.
- The world's largest public funder of biomedical research now faces a potential transformation from a merit-based institution into a politically gatekept apparatus, with consequences rippling across universities, hospitals, and research programs nationwide.
For decades, the National Institutes of Health has distributed its vast research funding through a process insulated from politics by the judgment of peer scientists — a structure built on the premise that knowledge, not ideology, should guide inquiry. Now, the Trump administration is preparing to insert a two-person political board with veto power over biomedical grants, effectively subordinating scientific merit to presidential priorities. The move, already preceded by billions in frozen funding and keyword-based filtering of research proposals, raises a question as old as patronage itself: when the sovereign controls the purse, can the mind remain free?
The Trump administration is moving to fundamentally alter how the National Institutes of Health awards research grants, inserting political oversight into a process that has long been governed by scientific peer review. According to reporting from the Washington Post and Politico, an executive order under discussion would create a board with veto authority over biomedical funding — with unanimous approval required, meaning either member could kill any grant.
The board would include Russell Vought, director of the Office of Management and Budget, and NIH director Jay Bhattacharya. During a Friday meeting where the plan was outlined, administration officials described existing NIH funding as supporting "woke" initiatives out of step with presidential priorities. Bhattacharya, who has publicly defended the NIH's traditional grant process, appears to be in tension with Vought's more aggressive posture — a fault line built into the structure itself.
The administration has not waited for the board to act. Since Trump's second term began, billions in grants tied to health, nutrition, environmental science, and disaster relief have been frozen or eliminated. Research proposals flagged for containing keywords like "equity," "racist," or "climate change" have already been filtered from consideration — a de facto censorship mechanism preceding any formal oversight body.
Researchers have filed a class-action lawsuit contending the administration is violating the First Amendment by using funding power to silence scientific viewpoints it disfavors. The legal argument draws a critical distinction: the government may choose what to fund, but it cannot selectively withhold funding to punish or suppress particular ideas. The NIH distributes tens of billions annually to institutions across the country, and concentrating approval in two presidentially accountable officials would eliminate the independent scientific judgment that has historically shielded research from partisan pressure. The Department of Health and Human Services and the White House declined to comment.
President Trump's administration is preparing to reshape how the National Institutes of Health awards research grants by inserting political oversight into a process that has historically relied on scientific merit alone. An executive order under discussion would establish a board with veto power over biomedical research funding, according to reporting from the Washington Post and Politico based on a Friday meeting where senior officials outlined the plan.
The proposed board would include Russell Vought, director of the White House Office of Management and Budget, and Jay Bhattacharya, the NIH director. Critically, the board would operate under a requirement for unanimous approval of grants—meaning either member could block funding for any research project. This structure represents a fundamental departure from how the NIH has operated for decades, when peer scientists evaluated proposals based on the quality of the research design and the likelihood of advancing human knowledge.
During the Friday meeting, administration officials characterized existing NIH funding as supporting "woke" initiatives misaligned with the president's political priorities. Vought, whose office is responsible for implementing presidential policy across federal agencies, has expressed a desire to reshape federal spending patterns. Bhattacharya, by contrast, has publicly resisted cuts to research funding and defended the NIH's traditional grant-making process, creating tension within the proposed oversight structure.
The administration has already moved aggressively on research funding since Trump took office for his second term. Billions of dollars in federal grants related to health, nutrition, environmental science, and disaster relief have been frozen or cut. The administration has flagged research proposals containing specific keywords—including "equity," "racist," "gender," and "climate change"—to restrict their access to federal funding. This keyword-based filtering has effectively created a de facto censorship mechanism before the proposed board would even convene.
The legal challenge to these actions is already underway. Researchers have filed a class-action lawsuit arguing that the administration is violating the First Amendment by weaponizing its funding power to silence scientific viewpoints the president disfavors. The lawsuit contends that while the government has the right to decide how to spend taxpayer money, it cannot use that power to target or suppress particular viewpoints within the scientific community. The distinction matters: the government can choose not to fund something, but it cannot fund selectively based on the researcher's political views or the ideological implications of their findings.
The NIH is the world's largest public funder of biomedical research, distributing tens of billions annually to universities, hospitals, and research institutions across the country. The proposed board structure would concentrate approval authority in two people, both appointed by or answerable to the president, eliminating the buffer of independent scientific judgment that has historically insulated research funding from partisan pressure. The Department of Health and Human Services, which oversees the NIH, and the White House declined to comment when asked about the plan.
Citazioni salienti
What the First Amendment does not allow is the government's use of its funding power to target or silence the expression of disfavored viewpoints within the biomedical research community.— Class-action lawsuit filed by researchers
Vuoi la storia completa?
Leggi l'originale su The Guardian ↗
Politics & Governance